📰 Bone Sarcoma Group News
Bone Sarcoma Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bone Sarcoma Group. Real-time updates on events, politics, business and more.
November 6, 2023
Tests comparing artificial intelligence and standard biopsies revealed that AI had an 86% greater success rate than its competitor, suggests new researc...
November 6, 2023
A recent study conducted by the Royal Marsden NHS Foundation Trust and the Institute of Cancer Research (ICR) highlights AI's capabilities in assessing cancer aggressiveness.
November 1, 2023
Recent advances in artificial intelligence (AI) are now poised to revolutionize the diagnostic procedures for sarcomas, a rare cancer type.
November 1, 2023
Researchers have developed an algorithm that predicts how aggressive a tumour is likely to be more accurately than a biopsy.
November 1, 2023
Researchers in UK say new tool could help ensure patients at high risk are identified promptly
June 5, 2023
FDA Extending PDUFA Date by Three Months to Allow More Time to Complete Their Review; New PDUFA Date Set to November 27, 2023STAMFORD, Conn., June 05, 2023 -- SpringWorks Therapeutics, Inc. , a... | June 5, 2023
May 25, 2023
- Nirogacestat Treatment Demonstrated Rapid, Sustained and Consistent Reductions in Pain Compared to Placebo Using Multiple Assessment Tools - - Substantial Reductions in MRI-Assessed Tumor Volume... | May 25, 2023
December 27, 2022
STAMFORD, Conn., Dec. 27, 2022 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on...
October 27, 2022
Sorry, but your browser does not support the video tag.
September 10, 2022
– Nirogacestat Treatment Resulted in Rapid, Sustained and Statistically Significant Improvements in Primary and All Key Secondary Efficacy Endpoints – –...